Boulder Wealth Advisors’s Elevance Health ELV Stock Holding History

Boulder Wealth Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$5K	Buy	+10	New	+$5.08K	﹤0.01%	93

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Boulder Wealth Advisors's ELV Position: Q4 2022 in Review

Boulder Wealth Advisors opened a new position in Elevance Health (ELV) in Q4 2022: 10 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #93 among its holdings.

1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Boulder Wealth Advisors held 10 shares of Elevance Health worth $5K as of Q4 2022.
Elevance Health was a new Boulder Wealth Advisors position in Q4 2022.
Elevance Health made up ﹤0.01% of Boulder Wealth Advisors's portfolio in Q4 2022, its #93 holding.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Boulder Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.